HLA-A and breast cancer in West Peninsular Malaysia

Medical Oncology

Volumn 28, Issue 1, 2011, Pages 51-56

  Leong, Pooi Pooi ^a   Muhammad, Rohaizak ^b   Ibrahim, Naqiyah ^b   Cheong, Soon Keng ^c   Seow, Heng Fong ^d  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^c UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

^d VICTORIA UNIVERSITY   (Australia)

Author keywords

Breast cancer; Her2; Heterzygous; HLA A; Homozygous; Metastasis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; HLA A ANTIGEN; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IMMUNOREACTIVITY; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALAYSIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; FEMALE; HLA-A ANTIGENS; HUMANS; LYMPHATIC METASTASIS; MALAYSIA; MIDDLE AGED;

EID: 79952249291     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9414-6     Document Type: Article

References (40)

1. AM Little PL Stern 1999 Does HLA type predispose some individuals to cancer? Mol Med Today 5 8 337 342 10431166 10.1016/S1357-4310(99)01524-5 1:CAS:528:DyaK1MXlslehurk%3D (Pubitemid 29364560)
2. CE Larsen CA Alper 2004 The genetics of HLA-associated disease Curr Opin Immunol 16 5 660 667 15342014 10.1016/j.coi.2004.07.014 1:CAS:528: DC%2BD2cXntleksbY%3D (Pubitemid 39165895)
3. HK Machulla F Steinborn A Schaaf V Heidecke NG Rainov 2001 Brain glioma and human leukocyte antigens (HLA)-is there an association J Neurooncol 52 3 253 261 11519856 10.1023/A:1010612327647 1:STN:280:DC%2BD3Mvns1ygsw%3D%3D (Pubitemid 33638525)
4. FS Oguz S Kalayoglu AS Diler H Tozkir D Sargin M Carin, et al. 2003 HLA system affects the age-at-onset in chronic myeloid leukemia Am J Hemato l73 4 256 262 10.1002/ajh.10365 (Pubitemid 36898883)
5. JD Carreon MP Martin A Hildesheim X Gao M Schiffman R Herrero, et al. 2005 Human leukocyte antigen class I and II haplotypes and risk of cervical cancer Tissue Antigens 66 4 321 324 16185329 10.1111/j.1399-0039.2005.00478.x 1:STN:280:DC%2BD2MrhsValtA%3D%3D (Pubitemid 41406671)
6. R Rompel J Petres K Kaupert G Muller-Eckhardt 1995 Human leukocyte antigens and multiple basal cell carcinomas Recent Results Cancer Res 139 297 302 7597298 1:STN:280:DyaK2MzitVCnsg%3D%3D
7. T Yokoe Y Iino H Takei J Horiguchi Y Koibuchi M Maemura, et al. 1997 HLA antigen as predictive index for the outcome of breast cancer patients with adjuvant immunochemotherapy with PSK Anticancer Res 17 4A 2815 2818 9252721 1:CAS:528:DyaK2sXlsFajtr0%3D (Pubitemid 27352693)
8. K Ogoshi T Tajima T Mitomi H Makuuchi K Tsuji 1997 HLA-A2 antigen status predicts metastasis and response to immunotherapy in gastric cancer Cancer Immunol Immunother 45 1 53 59 9353427 10.1007/s002620050400 1:STN:280: DyaK1c%2FhsVOhtw%3D%3D (Pubitemid 27444470)
9. A Concha F Esteban T Cabrera F Ruiz-Cabello F Garrido 1991 Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer Semin Cancer Biol 2 1 47 54 1912518 1:STN:280:DyaK38%2FgtlOhtA%3D%3D
10. T Shiina H Inoko JK Kulski 2004 An update of the HLA genomic region, locus information, disease associations: 2004 Tissue Antigens 64 6 631 649 15546336 10.1111/j.1399-0039.2004.00327.x 1:CAS:528:DC%2BD2MXmsFehsg%3D%3D (Pubitemid 39628044)
11. Lim GCC, Halimah Y. Cancer incidence in Malaysia 2003. Second report of the Nasional Cancer Registry 2004.
12. AN Hisham CH Yip 2004 Overview of breast cancer in Malaysian women: a problem with late diagnosis Asian J Surg 27 2 130 133 15140665 10.1016/S1015-9584(09)60326-2 (Pubitemid 38619645)
13. P Thongsuksai V Chongsuvivatwong H Sriplung 2000 Delay in breast cancer care: a study in Thai women Med Care 38 1 108 114 10630725 10.1097/00005650- 200001000-00012 1:STN:280:DC%2BD3c%2FpsVChsw%3D%3D
14. K Usmani A Khanum H Afzal N Ahmad 1996 Breast carcinoma in Pakistani women J Environ Pathol Toxicol Oncol 15 2-4 251 253 9216816 1:STN:280: DyaK2szlvF2jsg%3D%3D (Pubitemid 27280417)
15. I Harirchi M Ebrahimi N Zamani S Jarvandi A Montazeri 2000 Breast cancer in Iran: a review of 903 case records Public Health 114 2 143 145 10800155 10.1016/S0033-3506(00)00324-3 1:STN:280:DC%2BD3c3mtFyksg%3D%3D (Pubitemid 30206833)
16. MN Okobia CH Bunker JM Zmuda U Osime ER Ezeome SN Anyanwu, et al. 2006 Anthropometry and breast cancer risk in Nigerian women Breast J 12 5 462 466 16958966 10.1111/j.1075-122X.2006.00304.x (Pubitemid 44337440)
17. DP Rose R Royak-Schaler 2001 Tumor biology and prognosis in black breast cancer patients: a review Cancer Detect Prev 25 1 16 31 11270418 1:STN:280:DC%2BD3M7nsVOhtA%3D%3D
18. BM Biswal R Kumar PK Julka U Sharma MC Vaidya 1998 Human leucocytic antigens (HLA) in breast cancer Indian J Med Sci 52 5 177 183 9808907 1:STN:280:DyaK1M%2Fis1Cgtw%3D%3D
19. T Yokoe T Ishida T Ogawa Y Iino M Izuo 1990 Relationship of breast cancer and HLA in Japanese females Gan No Rinsho 36 1 29 33 2299789 1:STN:280:DyaK3c7jsVeisw%3D%3D
20. C Gourley C Thornton C Massie RJ Prescott M Turner RC Leonard, et al. 2003 Is there a relationship between HLA type and prognostic factors in breast cancer? Anticancer Res 23 1B 633 638 12680159 1:STN:280:DC%2BD3s7mtlKhug%3D%3D (Pubitemid 36358464)
21. Z Dehqanzada MT Hueman CD Shriver S Ponniah GE Peoples 2005 Prognostic significance of HLA-A2 status in breast cancer patients J Clin Oncol 23 16S, Part I of II (June 1 Supplement) 9702
22. Nagata Y, Hanagiri T, Mizukami M, Kuroda K, Shigematsu Y, Baba T, et al. Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan. Lung Cancer;In Press, Corrected Proof.
23. DF Kostiuchek NM Anichkov ZK Gamzatova GV Masucchi K Bergfedt L Villabona 2006 Expression of the major histocompability complex HLA-A2 gene in ovarian cancer Arkh Patol 68 6 3 6 17290883 1:STN:280:DC%2BD2s%2FpsVWqsA%3D%3D
24. P Kiewe V Mansmann C Scheibenbogen HJ Buhr E Thiel D Nagorsen 2008 HLA-A2 expression, stage, and survival in colorectal cancer Int J Colorectal Dis 23 8 767 772 18461337 10.1007/s00384-008-0488-y
25. MT Hueman ZA Dehqanzada TE Novak JM Gurney MM Woll GB Ryan, et al. 2005 Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients Clin Cancer Res 11 20 7470 7479 16243821 10.1158/1078-0432.CCR-05-0235 1:CAS:528:DC%2BD2MXhtFartbvE (Pubitemid 41507708)
26. IA Kouerinis G Zografos KE Tarassi TH Athanasiades M Liontos VG Gorgoulis, et al. 2004 Human leukocyte antigens as genetic markers in Greek patients with sporadic pancreatic cancer Pancreas 29 1 41 44 15211110 10.1097/00006676-200407000-00054 1:STN:280:DC%2BD2czitVGhtw%3D%3D (Pubitemid 38857265)
27. A Konieczna G Turowski 1993 HLA-ABC antigens in supraglottic cancer patients and their relationship with incidence and survival Mater Med Pol 25 2 73 79 8072312 1:STN:280:DyaK2czlt1Smug%3D%3D
28. VK Rakyan T Hildmann KL Novik J Lewin J Tost AV Cox, et al. 2004 DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project PLoS Biol 2 12 e405 15550986 10.1371/journal.pbio.0020405 (Pubitemid 40284135)
29. MC Lorincz D Schubeler SR Hutchinson DR Dickerson M Groudine 2002 DNA methylation density influences the stability of an epigenetic imprint and Dnmt3a/b-independent de novo methylation Mol Cell Biol 22 21 7572 7580 12370304 10.1128/MCB.22.21.7572-7580.2002 1:CAS:528:DC%2BD38XotVKhsb0%3D
30. NC Cheng M Beitsma A Chan I Op den Camp A Westerveld J Pronk, et al. 1996 Lack of class I HLA expression in neuroblastoma is associated with high N-myc expression and hypomethylation due to loss of the MEMO-1 locus Oncogene 13 8 1737 1744 8895520 1:CAS:528:DyaK28XmvVSht70%3D (Pubitemid 26377506)
31. N Cereb SY Yang 1994 The regulatory complex of HLA class I promoters exhibits locus-specific conservation with limited allelic variation J Immunol 152 8 3873 3883 8144957 1:CAS:528:DyaK2MXotlCg (Pubitemid 24111059)
32. MA Hall JS Lanchbury PJ Ciclitira 1996 HLA class II region genes and susceptibility to dermatitis herpetiformis: DPB1 and TAP2 associations are secondary to those of the DQ subregion Eur J Immunogenet 23 4 285 296 8858285 10.1111/j.1744-313X.1996.tb00124.x 1:STN:280:DyaK2s%2FhtFaktw%3D%3D (Pubitemid 26254667)
33. S Vukmanovic TA Neubert FR Santori 2003 Could TCR antagonism explain associations between MHC genes and disease? Trends Mol Med 9 4 139 146 12727139 10.1016/S1471-4914(03)00029-7 1:CAS:528:DC%2BD3sXjt1Cntrg%3D (Pubitemid 36626702)
34. MS Mitchell W Harel S Groshen 1992 Association of HLA phenotype with response to active specific immunotherapy of melanoma J Clin Oncol 10 7 1158 1164 1607920 1:STN:280:DyaK38zgtVChsg%3D%3D
35. CN Baxevanis PA Sotiropoulou NN Sotiriadou M Papamichail 2004 Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy Cancer Immunol Immunother 53 3 166 175 14685781 10.1007/s00262-003-0475-7 1:CAS:528:DC%2BD2cXhtlehsLY%3D (Pubitemid 38328039)
36. DP Dubey I Yunis CA Leslie C Mehta EJ Yunis 1987 Homozygosity in the major histocompatibility complex region influences natural killer cell activity in man Eur J Immunol 17 1 61 66 3816935 10.1002/eji.1830170111 1:STN:280:DyaL2s7jtlymsg%3D%3D (Pubitemid 17039328)
37. S Kulkarni MP Martin M Carrington 2008 The Yin and Yang of HLA and KIR in human disease Semin Immunol 20 6 343 352 18635379 10.1016/j.smim.2008.06.003 1:CAS:528:DC%2BD1cXhsVCgtr3F
38. P Hansasuta T Dong H Thananchai M Weekes C Willberg H Aldemir, et al. 2004 Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific Eur J Immunol 34 6 1673 1679 15162437 10.1002/eji.200425089 1:CAS:528: DC%2BD2cXltFKru7k%3D (Pubitemid 39256049)
39. M Stern L Ruggeri M Capanni A Mancusi A Velardi 2008 Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1 Blood 112 3 708 710 18502829 10.1182/blood-2008-02-137521 1:CAS:528:DC%2BD1cXpsVaisrw%3D
40. G Ahlenstiel MP Martin X Gao M Carrington B Rehermann 2008 Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses J Clin Invest 118 3 1017 1026 18246204 1:CAS:528: DC%2BD1cXivFemsL8%3D (Pubitemid 351364609)